Faculty profile

Paxton Bach

ResearcherUniversity of British Columbia

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of British Columbia directory, so their courses may be missing. Find their university profile.

Paxton Bach

Researcher

Health Sciences

University of British Columbia

Vancouver, British Columbia, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
52 publications in the last five years, latest in 2026.
Senior (last) author on 4 recent papers, a sign of leading a research group.
Principal investigator on 2 research grants (2 CIHR), most recently in 2026.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

Citations

h-index

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Addiction Contingency Management Health Incentives Incentivized Treatment Opioid Use Disorder Overdose Crisis People Who Use Drugs Socioeconomic Insecurity

Latest papers

Real-world comparative effects of slow-release oral morphine vs. methadone on healthcare use for opioid use disorder: A population-based target trial emulation.
Addiction (Abingdon, England) · 2026
Prescribed alternative stimulants among people who use unregulated stimulants: Examining the association between maximum dose reached and medication discontinuation in the first 3 years of implementation in British Columbia, Canada.
Addiction (Abingdon, England) · 2026
Managing benzodiazepine dependence arising from use of the adulterated opioid supply: a commentary.
Substance abuse treatment, prevention, and policy · 2026 · senior author

All 80 publications

Latest funding

Engagement-focused contingency management for the treatment of opioid use disorder: a randomized controlled trial
CIHR · 2026 · Principal investigator
$910,350
Advancing co-produced research priorities to respond to the overdose public health emergency in British Columbia
CIHR · 2025 · Co-investigator
$150,000
Canadian Research Initiative in Substance Misuse: BC Node
CIHR · 2022 · Co-investigator
$2,400,000

All 6 grants and awards

80 publications.

Real-world comparative effects of slow-release oral morphine vs. methadone on healthcare use for opioid use disorder: A population-based target trial emulation.

Zhou VY, Fairbairn N, Lei J, Brar R, Bach P, Socias ME

Addiction (Abingdon, England)2026

DOI: 10.1111/add.70543 PMID: 42464066

Prescribed alternative stimulants among people who use unregulated stimulants: Examining the association between maximum dose reached and medication discontinuation in the first 3 years of implementation in British Columbia, Canada.

Zhao B, Hu K, Desai R, Au S, Sedgemore KO, Tardelli V, Carter A, Bach P, Schutz C, Slaunwhite A, Crabtree A, Palis H

Addiction (Abingdon, England)2026

DOI: 10.1111/add.70580 PMID: 42621749

Managing benzodiazepine dependence arising from use of the adulterated opioid supply: a commentary.

Parmar G, Malette N, Ross J, Crabtree A, Bach P

Substance abuse treatment, prevention, and policy2026Senior author

DOI: 10.1186/s13011-026-00747-0 PMID: 42477718

Timing of Initiation of Methadone Take-Home Dosing.

Hossain MB, Min JE, Kurz M, Seaman S, Bach P, Karim ME, Bruneau J, Socias ME, Gustafson P, Platt R, Greenland S, Nosyk B

JAMA internal medicine2026

DOI: 10.1001/jamainternmed.2026.3904 PMID: 42709433

Uptake and Retention on Prescribed Psychostimulants for Harm Reduction: A Canadian Cohort Study.

Bach P, Choi J, Mok WY, Milloy MJ, DeBeck K, Kerr T, Hayashi K

Substance use & addiction journal2026First author

DOI: 10.1177/29767342261443853 PMID: 42105331

Comparative effectiveness of alternative times to opioid agonist treatment taper initiation on taper completion and all-cause mortality among people with opioid use disorder: A retrospective population-based target trial emulation study in British Columbia, Canada, 2010-2020.

Yan R, Min JE, Kurz M, Seaman SR, Bach P, Greenland S, Gustafson P, Karim ME, McCandless L, Platt RW, Siebert U, Socías ME, Xie H, Nosyk B

Addiction (Abingdon, England)2026

DOI: 10.1111/add.70489 PMID: 42227316

Use of benzodiazepines and medications for opioid use disorder for withdrawal management in a hospital-based setting for individuals exposed to benzodiazepine-contaminated fentanyl: A case series

Wong A, Nolan S, Bach P, Janssen RM, De Wolfe TJ, Dickhout P, Beauchesne R, Yang F, Johnson C, Carter A

Drug and Alcohol Dependence Reports2026

DOI: 10.1016/j.dadr.2026.100439

Comparative effectiveness of methadone take-home dose initiation in British Columbia, Canada: protocol for a population-based retrospective cohort study using target trial guidelines.

Hossain MB, Guerra-Alejos BC, Kurz M, Min JE, Karim ME, Seaman S, Bach P, Platt RW, Gustafson P, Bruneau J, McCandless L, Socías ME, Nosyk B

BMJ open2025

DOI: 10.1136/bmjopen-2024-095198 PMID: 40044208

Effectiveness of slow-release oral morphine versus other OAT regimens in key sub-populations: protocol for population-based target trial emulation.

Mondol MH, Min JE, Zanette M, Socías ME, Gustafson P, Bach P, Platt RW, Seaman S, Greenland S, Nosyk B

medRxiv : the preprint server for health sciences2025

DOI: 10.64898/2025.11.30.25341316 PMID: 41573342

Comparative effectiveness of urine drug testing schedules alongside opioid agonist treatment: Emulation of a population-based target trial in British Columbia, Canada.

Kurz M, Guerra-Alejos BC, Min JE, Seaman SR, Piske M, Bach P, Bruneau J, Greenland S, Gustafson P, Kampman K, Karim ME, Korthuis PT, Platt RW, Siebert U, Socías ME, Wood E, Nosyk B

Addiction (Abingdon, England)2025

DOI: 10.1111/add.70171 PMID: 40887310

Engagement-focused contingency management for the treatment of opioid use disorder: a randomized controlled trial

Principal investigatorCIHR2026Project Grant

Principal investigators: Fairbairn, Nadia S; Bach, Paxton J; Richardson, Lindsey

Keywords: Addiction; Contingency Management; Health Incentives; Incentivized Treatment; Opioid Use Disorder; Overdose Crisis; People Who Use Drugs; Socioeconomic Insecurity; Substance Use

$910,350

Advancing co-produced research priorities to respond to the overdose public health emergency in British Columbia

Co-investigatorCIHR2025Catalyst Grant: Partnering for Impact - Strategy for Patient-Oriented Research

Principal investigators: Palis, Heather; Davison, Carolyn; Buxton, Jane

Keywords: Health Equity; Overdose; Priority Setting; Public Health Emergency; Social Determinants Of Health; Unregulated Drug Supply

$150,000

Canadian Research Initiative in Substance Misuse: BC Node

Co-investigatorCIHR2022Team Grant: CRISM Phase II: Regional Nodes

Principal investigators: Wood, Evan; Tupper, Kenneth; Fairbairn, Nadia S; Johnson, Cheyenne H; Nolan, Seonaid; Socías, María E

Keywords: Addiction; Clinical Trials; Hiv/Aids; Substance Use

$2,400,000

In the shadows of the opioid crisis: the epidemiology and impact of methamphetamine use in Canada

Principal investigatorCIHR2019Operating Grant: Methamphetamine and related psychostimulant use

Principal investigators: Cragg, Jacquelyn J; Lysyshyn, Mark; Bach, Paxton J

Keywords: Administrative Data; Demographic Trends; Epidemiology; Geographic Trends; Hospitalizations; Methamphetamine; Temporal Trends

$100,000

Concurrent Use and Transition to Methamphetamine among persons at risk of OverDose (CUT Meth OD)

Co-investigatorCIHR2019Operating Grant: Methamphetamine and related psychostimulant use

Principal investigators: Buxton, Jane; Corneil, Trevor A

Keywords: Epidemiology; Harm Reduction; Methamphetamine; Polysusbtance Use; Qualitative Interviews

$100,000

What works for methamphetamine use disorder? A systematic review of reviews

Co-investigatorCIHR2019Operating Grant: Methamphetamine and related psychostimulant use

Principal investigators: Buxton, Jane; Lysyshyn, Mark; Karamouzian, Mohammad

Keywords: Harm Reduction; Methamphetamine; Substance Use Disorders; Substance Use Treatment

$93,967

From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.

Something wrong or missing on this profile? Suggest a correction

Paxton Bach

Research

Latest papers

Latest funding

Real-world comparative effects of slow-release oral morphine vs. methadone on healthcare use for opioid use disorder: A population-based target trial emulation.

Prescribed alternative stimulants among people who use unregulated stimulants: Examining the association between maximum dose reached and medication discontinuation in the first 3&#x2009;years of implementation in British Columbia, Canada.

Managing benzodiazepine dependence arising from use of the adulterated opioid supply: a commentary.

Timing of Initiation of Methadone Take-Home Dosing.

Uptake and Retention on Prescribed Psychostimulants for Harm Reduction: A Canadian Cohort Study.

Comparative effectiveness of alternative times to opioid agonist treatment taper initiation on taper completion and all-cause mortality among people with opioid use disorder: A retrospective population-based target trial emulation study in British Columbia, Canada, 2010-2020.

Use of benzodiazepines and medications for opioid use disorder for withdrawal management in a hospital-based setting for individuals exposed to benzodiazepine-contaminated fentanyl: A case series

Comparative effectiveness of methadone take-home dose initiation in British Columbia, Canada: protocol for a population-based retrospective cohort study using target trial guidelines.

Effectiveness of slow-release oral morphine versus other OAT regimens in key sub-populations: protocol for population-based target trial emulation.

Comparative effectiveness of urine drug testing schedules alongside opioid agonist treatment: Emulation of a population-based target trial in British Columbia, Canada.

Engagement-focused contingency management for the treatment of opioid use disorder: a randomized controlled trial

Advancing co-produced research priorities to respond to the overdose public health emergency in British Columbia

Canadian Research Initiative in Substance Misuse: BC Node

In the shadows of the opioid crisis: the epidemiology and impact of methamphetamine use in Canada

Concurrent Use and Transition to Methamphetamine among persons at risk of OverDose (CUT Meth OD)

What works for methamphetamine use disorder? A systematic review of reviews

Frequent collaborators

Kanna Hayashi

Bohdan Nosyk

Bohdan Nosyk

Evan Wood

Kanna Hayashi

Thomas Kerr

Nadia Fairbairn

Seonaid Nolan

Lianping Ti

Julie Bruneau

Bernard Le Foll

Britt Dennis

Lawrence McCandless

Amanda Slaunwhite

Heather Palis

Tea Rosic

Julio Montaner

Didier Jutras-Aswad

Zainab Samaan

Brittany Barker

Brittany Barker

Cheyenne Johnson

Lindsay Hedden

Lindsay Hedden

Claire de Oliveira

Karen Urbanoski

Joanna Dionne

Kora DeBeck

Mohammad Karamouzian

Kali-olt Sedgemore

Nikki Bozinoff

Samantha Young

Sara Davidson

Nicholas Chadi

Hudson Reddon

Karen Urbanoski

Prescribed alternative stimulants among people who use unregulated stimulants: Examining the association between maximum dose reached and medication discontinuation in the first 3 years of implementation in British Columbia, Canada.